Vivos RDGL
OTC RDGL
$0.05 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Vivos (RDGL) Cash from Financing Activities (2010 - 2025)

Vivos' (RDGL) quarterly Cash from Financing Activities came in at -$845.0 in Q4 2025, down 100.06% year-over-year from $1.5 million in Q4 2024, and down 100.06% quarter-over-quarter from $1.5 million in Q1 2025.

Analysis

Vivos (RDGL) Cash from Financing Activities (2010 - 2025) Analysis & Trends

Vivos has disclosed Cash from Financing Activities across 15 years of filings, most recently posting -$845.0 for Q4 2025.

  • In Q4 2025, Cash from Financing Activities fell 100.06% year-over-year to -$845.0; the TTM figure through Dec 2025 stood at $1.5 million (down 34.6% YoY), while the FY2025 annual figure was $1.5 million, down 34.6% from the prior year.
  • Cash from Financing Activities came in at -$845.0 for Q4 2025 at Vivos, down from $1.5 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $1.8 million in Q1 2021 to a low of -$145000.0 in Q4 2021.
  • Average Cash from Financing Activities over 4 years is $667335.9, with a median of $518580.0 recorded in 2023.
  • The largest YoY upside for Cash from Financing Activities was 2420.16% in 2021 against a maximum downside of 111.56% in 2021.
  • Over 4 years, Cash from Financing Activities stood at -$145000.0 in 2021, then surged by 457.64% to $518580.0 in 2023, then jumped by 182.56% to $1.5 million in 2024, then tumbled by 100.06% to -$845.0 in 2025.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$845.0 in Q4 2025, $1.5 million in Q1 2025, and $1.5 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -287.90 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -343.00 Mn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -300,000.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -510.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -607.30 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -213.50 Mn
10 Vivos 23.21 Mn 23.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -845.00
Mar 31, 2025 1.51 Mn
Dec 31, 2024 1.47 Mn
Jun 30, 2024 709,000.00
Mar 31, 2024 130,000.00
Dec 31, 2023 518,580.00
Sep 30, 2023 10,000.00
Dec 31, 2021 -145,000.00
Mar 31, 2021 1.81 Mn
Dec 31, 2020 1.25 Mn
Sep 30, 2020 -50,000.00
Jun 30, 2020 482,910.00
Mar 31, 2020 71,870.00
Dec 31, 2019 115,000.00
Sep 30, 2019 335,000.00
Jun 30, 2019 94,000.00
Mar 31, 2019 308,000.00
Dec 31, 2018 538,140.00
Sep 30, 2018 70,932.00
Jun 30, 2018 48,559.00